State Street’s ESSA Pharma EPIX Stock Holding History

State Street’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-24,414	Closed	-$65.9K	–	4572
2023 Q2	$65.9K	Sell	24,414 -438	-2%	-$1.28K	﹤0.01%	4340
2023 Q1	$73.8K	Sell	24,852 -109	-0.4%	-$320	﹤0.01%	4407
2022 Q4	$62.9K	Buy	24,961 +110	+0.4%	+$316	﹤0.01%	4502
2022 Q3	$45K	Sell	24,851 -5,860	-19%	-$15.4K	﹤0.01%	4678
2022 Q2	$97K	Sell	30,711 -33,839	-52%	-$189K	﹤0.01%	4551
2022 Q1	$399K	Buy	64,550 +700	+1%	+$6.15K	﹤0.01%	4134
2021 Q4	$907K	Buy	63,850 +30,440	+91%	+$339K	﹤0.01%	3837
2021 Q3	$267K	Buy	+33,410	New	+$531K	﹤0.01%	4245

Other funds holding EPIX

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return

State Street's EPIX Position: Q3 2023 in Review

State Street sold out of ESSA Pharma (EPIX) in Q3 2023, closing a stake of 24,414 shares — an estimated $65.9K sold.

State Street first reported a position in EPIX in Q3 2021 and held it in 8 quarters. The position peaked at $907K in Q4 2021. 36 funds tracked by Wall St. Rank hold EPIX as of Q3 2023.

State Street reported no remaining ESSA Pharma position as of Q3 2023 after selling out during the quarter.
State Street sold 24,414 ESSA Pharma shares in Q3 2023, an estimated $65.9K.
State Street first reported a position in ESSA Pharma in Q3 2021 and held it in 8 quarters.
State Street's ESSA Pharma position peaked at $907K in Q4 2021.
36 funds tracked by Wall St. Rank held ESSA Pharma as of Q3 2023.

Based on State Street's 13F filing for Q3 2023, filed 14 Nov 2023.